oxycodone drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| oxycodone | risk_factor_for | addiction | — | 1 |
| oxycodone | risk_factor_for | opioid dependence | — | 1 |
| oxycodone | targets | OPRM1 | — | 1 |
| United States | associated_with | oxycodone | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health. (2018)
- Pharmacogenetics of OPRM1. (2014)
- Modeling transformations of neurodevelopmental sequences across mammalian species. (2013)
- Adolescent initiation of licit and illicit substance use: Impact of intrauterine exposures and post-natal exposure to violence. (2011)
- From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. (2009)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| oxycodone | drug | 8 | 11 |